Adenine Deoxyribonucleoside
Adenine Deoxyribonucleoside Brand names, Adenine Deoxyribonucleoside Analogs
Adenine Deoxyribonucleoside Brand Names Mixture
- No information avaliable
Adenine Deoxyribonucleoside Chemical_Formula
C10H13N5O4
Adenine Deoxyribonucleoside RX_link
http://www.rxlist.com/cgi/generic3/adenos.htm
Adenine Deoxyribonucleoside fda sheet
Adenine Deoxyribonucleoside msds (material safety sheet)
Adenine Deoxyribonucleoside Synthesis Reference
No information avaliable
Adenine Deoxyribonucleoside Molecular Weight
267.242 g/mol
Adenine Deoxyribonucleoside Melting Point
235.5 oC
Adenine Deoxyribonucleoside H2O Solubility
8230 mg/L
Adenine Deoxyribonucleoside State
Solid
Adenine Deoxyribonucleoside LogP
-0.722
Adenine Deoxyribonucleoside Dosage Forms
Liquid
Adenine Deoxyribonucleoside Indication
For controlling paroxysmal supraventricular tachycardia (PSVT). This drug can also be used diagnostically for stable, wide complex tachyardias of unknown type.
Adenine Deoxyribonucleoside Pharmacology
Adenosine is an endogenous nucleoside occurring in all cells of the body and is not chemically related to other antiarrhythmic drugs. Adenosine is indicated for the conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). Adenosine is antagonized competitively by methylxanthines such as caffeine and theophylline, and potentiated by blockers of nucleoside transport such as dipyridamole. Adenosine is not blocked by atropine.
Adenine Deoxyribonucleoside Absorption
No information avaliable
Adenine Deoxyribonucleoside side effects and Toxicity
No information avaliable
Adenine Deoxyribonucleoside Patient Information
No information avaliable
Adenine Deoxyribonucleoside Organisms Affected
Humans and other mammals
